Review
Accepted on 07 Jun 2023
Study on the Mechanism of Action of Colchicine in the Treatment of Coronary Artery Disease Based on Network Pharmacology and Molecular Docking Technology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1147360
Type at least 3 characters
996 articles
Articles
Original Research
Accepted on 06 Jun 2023
PRAVASTATIN REDUCES PLASMA LEVELS OF EXTRACELLULAR VESICLES IN PREGNANCIES AT HIGH RISK OF TERM PREECLAMPSIA
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1166123
Editorial
Accepted on 05 Jun 2023
Editorial: Targeting Inflammation to Prevent Complications in Stroke
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1229303
Original Research
Accepted on 30 May 2023
Protective Effect of Cafestol Against Doxorubicin-induced Cardiotoxicity in Rats by Activating Nrf2 Pathway
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1206782
Case Report
Accepted on 30 May 2023
Central retinal vein occlusion with cerebral infarction secondary to anlotinib treatment: a case report and literature review
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1188218
Original Research
Published on 30 May 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1093396
- 341 views
Original Research
Published on 30 May 2023
Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22/Sirt 1
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1164333
- 133 views
Original Research
Accepted on 26 May 2023
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1175606
Review
Published on 25 May 2023
Drug therapy for myocarditis induced by immune checkpoint inhibitors
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1161243
- 888 views
Original Research
Published on 23 May 2023
Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1148410
- 251 views
Original Research
Accepted on 22 May 2023
Increased plasma renin concentration by vasodilators promotes the progression of abdominal aortic aneurysm
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1174278
Original Research
Published on 17 May 2023
A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1159779
- 398 views
Original Research
Published on 12 May 2023
Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1170039
- 339 views
Original Research
Published on 05 May 2023
Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1127388
- 591 views
Review
Published on 05 May 2023
Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1167260
- 698 views
Original Research
Published on 25 Apr 2023
Preeclamptic programming unevenly perturbs inflammatory and renal vasodilatory outcomes of endotoxemia in rat offspring: modulation by losartan and pioglitazone
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1140020
- 417 views